01 November 2024
01 November 2024
The topline results showed that Amelus and BF-RhodoLED lamp therapy met primary and secondary endpoints in the Phase III trial.
The data was shared at the Clinical Trials on Alzheimer’s Disease (CTAD) conference in Madrid, Spain, on 31 October.
Reeves' budget promised investment for innovation and R&D with a view to "harnessing the full potential of the UK’s science base”.
The trial aims to recruit up to 410 additional patients for its pivotal phase across both countries.
The four AI-driven tools are designed to cover more than 30 indications and expedite patient diagnosis.
The implant utilises additive manufacturing techniques to create a porous structure that resembles a cancellous bone structure.
Alzheimer’s patients using the SinaptiStim system experienced a 44% reduction in disease progression over 12 months.
The partnership between Medable and Google Cloud Marketplace is designed to make it easier for healthcare firms to acquire and pay for the clinical trial software.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
